期刊文献+

颅骨弥漫性大B细胞淋巴瘤1例 被引量:1

暂未订购
导出
摘要 目的总结颅骨弥漫性大B细胞淋巴瘤诊治经验。方法回顾性分析1例颅骨弥漫性大B细胞淋巴瘤病例资料,分析颅骨淋巴瘤的临床特征、诊断及治疗。结果手术全切除肿瘤,病理诊断为弥漫性大B细胞淋巴瘤,出院后于外院行进一步化学治疗及生物治疗,随访5个月余肿瘤未复发。结论原发于颅骨的弥漫性大B细胞淋巴瘤少见,术后易复发,需辅以化疗与免疫治疗。
出处 《中国微侵袭神经外科杂志》 CAS 2019年第11期516-517,共2页 Chinese Journal of Minimally Invasive Neurosurgery
  • 相关文献

参考文献4

二级参考文献24

  • 1Fu K,Perry K,Smith L,et al.Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma[].Journal of Clinical Oncology.2007
  • 2Pfreundschuh M,Truemper L,Gill D,et al.First Analysis of the Completed Mabthera International (Mint)Trial in Young Patients with Low-Risk Diffuse Large B-Cell Lymphoma (DLBCL):Addition of Rituximab to a CHOP-Like Regimen Significantly Improves Outcome of All Patients with the Identification of[].Blood.2004
  • 3Pfreundschuh M,Kloess M,Schmits R,et al.Six,not eight cycles of bi-weekly CHOP with rituximab (R-CHOP-14)is the preferred treatment for elderly patients with diffuse large B-cell lymphoma (DLBCL):results of the RICOVER-60trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)[].Blood.2005
  • 4Morrison V,Weller E,Habermann T,et al.Maintenance rituximab (MR)compared to observation (OBS)after R-CHOP or CHOP in older patients (pts)with diffuse large B-cell lymphoma (DLBCL):An Intergroup E4494/C9793update[].Journal of Clinical Oncology.2007
  • 5Farinha P,Sehn L,Skinnider B,et al.Addition of Rituximab (R)to CHOP Improves Survival in the Non-GCB Subtype of Diffuse Large B Cell Lymphoma (DLBCL)[].Blood.2006
  • 6Habermann,TM,Weller,EA,Morrison,VA.Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma[].Journal of Clinical Oncology.2006
  • 7Wang,F,Xu,RH,Han,B,Shi,YX,Luo,HY,Jiang,WQ,Lin,TY,Huang,HQ,Xia,ZJ,Guan,ZZ.High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers[].Cancer.2007
  • 8Simpson ND,Simpson PW,Ahmed AM,et al.Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine[].Journal of Clinical Gastroenterology.2003
  • 9Li,YH,He,YF,Jiang,WQ,Wang,FH,Lin,XB,Zhang,L.Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma[].Cancer.2006
  • 10Lau GK,Yiu HH,Fong DY,et al.Early is superior to deferred pre-emptive lamivudine therapy for hepatitis B patients undergoing chemotherapy[].Gastroenterology.2003

共引文献8

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部